Leukoreduction of blood transfusions does not diminish transfusion‐associated microchimerism in trauma patients

BACKGROUND: Transfusion of trauma patients can result in long‐term survival of donor white blood cells (WBCs) or “transfusion‐associated microchimerism” (TA‐MC). The aim was to determine whether leukoreduction of blood transfusions, advocated to reduce the immunomodulatory effect of transfusion, decreases the likelihood of developing TA‐MC.

[1]  M. Busch,et al.  Enhanced ascertainment of microchimerism with real‐time quantitative polymerase chain reaction amplification of insertion‐deletion polymorphisms , 2006, Transfusion.

[2]  G. Rubenfeld,et al.  THE EFFECTS OF LEUKOREDUCED BLOOD TRANSFUSION ON INFECTION RISK FOLLOWING INJURY: A RANDOMIZED CONTROLLED TRIAL , 2006, Shock.

[3]  M. Busch,et al.  High‐level long‐term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury , 2005, Transfusion.

[4]  M. Busch,et al.  Microchimerism in transfused trauma patients is associated with diminished donor-specific lymphocyte response. , 2005, The Journal of trauma.

[5]  M. Busch,et al.  Blood transfusion is associated with donor leukocyte microchimerism in trauma patients. , 2004, The Journal of trauma.

[6]  K. M. Adams,et al.  Microchimerism: an investigative frontier in autoimmunity and transplantation. , 2004, JAMA.

[7]  J. Buyon,et al.  Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block , 2003, The Lancet.

[8]  J. Nelson,et al.  Microchimerism in Human Health and Disease , 2003, Autoimmunity.

[9]  M. Blajchman.  Immunomodulation and Blood Transfusion , 2002, American journal of therapeutics.

[10]  J. Nelson.  Microchimerism: expanding new horizon in human health or incidental remnant of pregnancy? , 2001, The Lancet.

[11]  Tzong-Hae Lee,et al.  Survival of donor leukocyte subpopulations in immunocompetent transfusion recipients: frequent long-term microchimerism in severe trauma patients. , 1999, Blood.

[12]  D. Furst,et al.  Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. , 1999, Blood.

[13]  D. Furst,et al.  Microchimerism and HLA-compatible relationships of pregnancy in scleroderma , 1998, The Lancet.

[14]  C. Sprung,et al.  Multiple Organ Dysfunction Score , 1996 .

[15]  C. Sprung,et al.  Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.

[16]  T. Nishiuchi,et al.  Transfusion-associated graft-versus-host disease caused by leukocyte-filtered stored blood. , 1993, Anesthesiology.

[17]  K. Oshimi,et al.  A case of transfusion‐associated graft‐versus‐host disease not prevented by white cell‐reduction filters , 1992, Transfusion.